Illumina, Inc. (ILMN) vs Mettler-Toledo International, Inc. (MTD)

Illumina, Inc. and Mettler-Toledo International, Inc. are both Diagnostics & Research companies. Illumina, Inc. and Mettler-Toledo International, Inc. are of similar size ($33.6B and $31.5B). Illumina, Inc. trades at the lower P/E: 35.6× against 37.6×. Mettler-Toledo International, Inc. grew revenue faster over the last twelve months: 6.91% against 5.83%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs 19.7%) and the higher return on invested capital (35.4% vs 16.7%). Across the 22 metrics below, Illumina, Inc. leads on 16 and Mettler-Toledo International, Inc. on 6.

Valuation

Metric ILMN MTD Diagnostics & Research median
P/E 35.62 37.65 34.52
P/S 6.98 8.16 4.24
P/B 10.07 2,631.36 3.42
Price to free cash flow 30.41 39.06 33.51
EV/EBITDA 26.35 27.43 23.44
EV/Sales 7.19 8.66 5.18
Earnings yield 2.81% 2.66% (1.50%)
Free cash flow yield 3.29% 2.56% 0.00%

Profitability

Metric ILMN MTD Diagnostics & Research median
Gross margin 67.87% 60.26% 48.32%
Operating margin 21.18% 28.41% (5.68%)
Net margin 19.72% 21.91% (4.10%)
Free cash flow margin 23.29% 20.90% 0.00%
Return on equity 32.39% (736.36%) 0.00%
Return on assets 13.78% 25.61% (6.05%)
Return on invested capital 16.70% 35.40% 0.00%

Growth

Metric ILMN MTD Diagnostics & Research median
Revenue growth (TTM) 5.83% 6.91% 8.99%
EPS growth (last fiscal year) 170.87% 3.88% 20.36%
Revenue growth, 5-year CAGR 6.04% 5.47% 7.30%
Net income growth, 5-year CAGR 5.32% 7.60% 0.00%

Health

Metric ILMN MTD Diagnostics & Research median
Debt to equity 0.57 164.70 0.01
Current ratio 2.63 1.12 2.27
Net debt to EBITDA (0.13) 1.68 0.68

Dividend

Metric ILMN MTD Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ILMN MTD Diagnostics & Research median
Market cap 31.45b 33.64b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack